November 17, 2020
Infinity Angioplasty Announces Successful First Case With Recently Cleared Platform
November 17, 2020—Infinity Angioplasty Balloon Company announced the completion of the first-in-human procedure of its Infinity angioplasty balloon catheter.
The first Infinity procedure was performed by John A. Phillips, MD, an interventional cardiologist at OhioHealth Riverside Methodist, in Columbus, Ohio. In the company’s announcement, Dr. Phillips commented, “I am extremely pleased with the catheter delivery and to-the-mm sizing of the balloon length to the lesion, particularly in this very challenging case. The patient was a 60-year-old woman with highly angulated aortic bifurcation and a 78-mm chronic total occlusion in the distal superficial femoral artery.”
In June 2020, the company announced that the FDA cleared the Infinity angioplasty balloon catheter for percutaneous transluminal angioplasty treatment of peripheral artery disease in the peripheral vasculature, including iliac, femoral, popliteal, and infrapopliteal arteries, and for the treatment of arteriovenous dialysis fistulas.
The company’s launch of the Infinity angioplasty balloon catheter will be followed by the introduction of the Infinity Defender, a drug-coated balloon platform of similar design that will assure precise delivery of drug to the lesion site and minimize downstream and systematic effects.